The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for H Matsumoto


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity.EBI
Takeda Pharmaceutical
Trypsin resistance of a decapeptide KISS1R agonist containing an N¿-methylarginine substitution.EBI
Takeda Pharmaceutical
Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides.EBI
Takeda Pharmaceutical
Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.EBI
Takeda Pharmaceutical
Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor.EBI
Takeda Chemical Industries
A study of novel antiallergic agents with eosinophilic infiltration inhibiting action.EBI
Tokushima Bunri University
Lanostane triterpenoids and triterpene glycosides from the fruit body of Fomitopsis pinicola and their inhibitory activity against COX-1 and COX-2.EBI
Tokushima Bunri University
'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.EBI
Kyoto Pharmaceutical University
A new class of anti-HIV agents: synthesis and activity of conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor.EBI
Kyoto Pharmaceutical University
3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.EBI
Tokushima Bunri University
Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.EBI
Kyoto Pharmaceutical University
Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension.EBI
Nagoya University
Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors.EBI
Kindai University
Design, synthesis, and evaluation of DNA topoisomerase II-targeted nucleosides.EBI
Kyoto University
SUBSTITUTED DIARYLAMINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOFBDB
Suzhou Yabao Pharmaceutical R&D